Cardlytics (NASDAQ:CDLX) CFO David Thomas Evans Acquires 150,000 Shares

Cardlytics, Inc. (NASDAQ:CDLX) CFO David Thomas Evans acquired 150,000 shares of the stock in a transaction that occurred on Friday, May 15th. The shares were bought at an average price of $0.65 per share, for a total transaction of $97,500.00. Following the purchase, the chief financial officer directly owned 267,930 shares of the company’s stock, valued at approximately $174,154.50. This trade represents a 127.19% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

David Thomas Evans also recently made the following trade(s):

• On Monday, May 18th, David Thomas Evans acquired 50,000 shares of Cardlytics stock. The shares were bought at an average price of $0.63 per share, for a total transaction of $31,500.00.

Cardlytics Price Performance

Shares of NASDAQ CDLX traded down $0.01 during mid-day trading on Tuesday, reaching $0.60. 865,741 shares of the company traded hands, compared to its average volume of 1,103,752. Cardlytics, Inc. has a fifty-two week low of $0.57 and a fifty-two week high of $3.28. The firm has a market cap of $34.34 million, a PE ratio of -0.34 and a beta of 0.67. The stock has a fifty day simple moving average of $0.87 and a 200-day simple moving average of $1.06.

Cardlytics (NASDAQ:CDLX) last posted its quarterly earnings data on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08). Cardlytics had a negative net margin of 46.03% and a negative return on equity of 956.56%. The company had revenue of $56.10 million for the quarter, compared to analyst estimates of $54.46 million. As a group, analysts predict that Cardlytics, Inc. will post -0.11 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Evercore set a $1.00 price objective on shares of Cardlytics in a research note on Friday, March 6th. Weiss Ratings restated a “sell (e+)” rating on shares of Cardlytics in a research report on Friday, April 10th. Wall Street Zen upgraded shares of Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday, April 4th. Lake Street Capital set a $1.00 price target on shares of Cardlytics in a research report on Friday, May 8th. Finally, Bank of America restated an “underperform” rating on shares of Cardlytics in a research report on Thursday, March 5th. One investment analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Sell” and a consensus price target of $1.00.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in CDLX. Vanguard Personalized Indexing Management LLC acquired a new position in Cardlytics in the third quarter worth approximately $26,000. Virtu Financial LLC acquired a new position in Cardlytics in the fourth quarter worth approximately $39,000. Qube Research & Technologies Ltd acquired a new position in Cardlytics in the third quarter worth approximately $55,000. Marshall Wace LLP acquired a new position in Cardlytics in the second quarter worth approximately $59,000. Finally, Renaissance Technologies LLC acquired a new position in Cardlytics in the fourth quarter worth approximately $62,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.